Beyond Air, Inc. Earnings Recaps
Q3 2026
Feb 13, 2026
Beyond Air reported a remarkable 105% year-over-year revenue increase to $2.2 million, driven by growing adoption of its LungFit PH system, and strategically strengthened its balance sheet through the sale of its NeuroNOS subsidiary.
Key takeaways
- Achieved significant revenue growth, with quarterly revenue reaching $2.2 million, reflecting strong market demand and increased hospital adoption.
- Over 45 hospitals currently utilize the first-generation LungFit PH system, with customer retention exceeding 90%.
- Completed the initial sale of LungFit PH to a VA Medical Center, marking a key milestone in expanding the company’s presence in federal healthcare systems.
- Expanded international distribution, now covering 40 countries, enhancing the company’s global footprint for long-term growth.
- Preparing for the anticipated FDA approval of the second-generation LungFit PH system, expected to enhance market reach and operational efficiency.